葛兰宣布，限购！

Core Viewpoint - The recent trend of fund subscription limits in the public offering market is increasing, with many funds implementing these measures to manage inflows and protect existing investors' interests [2][4]. Group 1: Fund Subscription Limits - On August 9, China Europe Fund announced subscription limits for its two funds, China Europe Sci-Tech Theme and China Europe Medical Innovation, effective August 11, with limits set at 1 million yuan and 100,000 yuan respectively [3]. - Since July, approximately 50 actively managed equity funds have announced subscription limits, including several high-performing products [4]. - The limits are seen as a strategy to control fund size, stabilize strategy execution, and reduce liquidity risks during periods of high market sentiment and inflows [2][4]. Group 2: Performance of Specific Funds - The China Europe Medical Innovation fund, managed by renowned fund manager Ge Lan, achieved a one-year return of 85.03% as of August 6, ranking in the top 2% of its category [3]. - Ge Lan previously implemented subscription limits during the 2021 medical sector rally, indicating a consistent approach to managing fund inflows [3]. - The China Europe Sci-Tech Theme fund, managed by Shao Jie, focuses on technology innovation and has benefited from the strong performance of the tech sector this year [3]. Group 3: Industry Insights - Industry experts suggest that proactive subscription limits during high market enthusiasm protect existing investors and reflect a commitment to disciplined investment practices [4][6]. - By setting subscription limits, fund companies aim to maintain stable positions and strategies, avoiding forced adjustments due to rapid growth in fund size [6]. - This approach is intended to help funds navigate market volatility and enhance long-term competitiveness while demonstrating a professional attitude towards investment discipline [6].